JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1610393

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goto, T
Right arrow Articles by Kudo, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goto, T
Right arrow Articles by Kudo, R
Journal of Endocrinology, Vol 161, Issue 3, 393-402
Copyright © 1999 by Society for Endocrinology


Articles

Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats

T Goto, T Endo, H Henmi, Y Kitajima, T Kiya, A Nishikawa, K Manase, H Sato, and R Kudo


Gonadotropin-releasing hormone (GnRH) and its agonist analog (GnRHa) are well known to have luteolytic effects. We previously reported that prolactin (PRL) stimulated matrix metalloproteinase (MMP)-2 activity to degrade collagen type IV as a mechanism of structural luteolysis. The effects of GnRHa treatment on developed corpora lutea are unknown. In this study we assessed the effect of GnRH on MMP expression and induction of structural involution of developed corpora lutea of superovulated rats using GnRHa. Pregnant mare serum gonadotropin-human chorionic gonadotropin (hCG)-synchronized ovulation and luteinization were induced in immature female rats, followed by daily treatment with GnRHa from 5 days after hCG treatment. GnRHa-induced involution of corpora lutea was evident 3 days after the treatment, as shown by their markedly smaller size (60% of the control weight). Nine days after hCG injection, serum progesterone and 20alpha-dihydroprogesterone concentrations were as low as those associated with structural luteolysis. These findings revealed that GnRHa has the ability to induce structural luteolysis in superovulated rats in the same way that PRL does. To gain information on mechanisms of luteal involution induced by GnRHa, we performed gelatin zymography. This showed a significant increase in the active form of MMP-2 in the luteal extract of GnRHa-treated rats (more than twofold that of the control). Activation of pro-MMP-2 by membrane type-MMP (MT-MMP) is reported to be a rate-limiting step for catalytic function. Another function of MT-MMP is to degrade collagen types I and III. The plasma membrane fraction of corpora lutea of GnRHa-treated rats activated pro-MMP-2 of fetal calf serum, resulting in a marked shift of the 68-kDa band to the 62-kDa band in the zymogram. A Northern hybridization study also revealed simultaneous significant increases in expression of MMP-2 mRNA and MT1-MMP mRNA in corpora lutea of GnRHa-treated rats (more than threefold the control level). In summary, hormonal and histological features of corpora lutea of GnRHa-treated superovulated rats correspond to those of structural luteolysis. GnRHa stimulated the expression of MMP-2 and MT1-MMP in developed corpora lutea associated with involution. These findings support the conclusion that MMP-2, activated by MT1-MMP, and MT1-MMP itself, remodel the extracellular matrix during structural luteolysis induced by GnRHa.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
K. Walters, I. N. Wegorzewska, Y.-P. Chin, M. G. Parikh, and T. J. Wu
Luteinizing Hormone-Releasing Hormone I (LHRH-I) and Its Metabolite in Peripheral Tissues
Experimental Biology and Medicine, February 1, 2008; 233(2): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. Ota, H. Yonemoto, A. Someya, S. Itoh, K. Kinoshita, and I. Nagaoka
Changes in Matrix Metalloproteinase 2 Activities in Amniochorions During Premature Rupture of Membranes
Reproductive Sciences, December 1, 2006; 13(8): 592 - 597.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-H. Choi, C. B. Gilks, N. Auersperg, and P. C. K. Leung
Immunolocalization of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Type I GnRH Receptor during Follicular Development in the Human Ovary
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4562 - 4570.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Kitajima, T. Endo, K. Nagasawa, K. Manase, H. Honnma, T. Baba, T. Hayashi, H. Chiba, N. Sawada, and T. Saito
Hyperstimulation and a Gonadotropin-Releasing Hormone Agonist Modulate Ovarian Vascular Permeability by Altering Expression of the Tight Junction Protein Claudin-5
Endocrinology, February 1, 2006; 147(2): 694 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. H. Shah, M. P. Farshori, and K. J. Catt
Neuropeptide-induced Transactivation of a Neuronal Epidermal Growth Factor Receptor Is Mediated by Metalloprotease-dependent Formation of Heparin-binding Epidermal Growth Factor
J. Biol. Chem., January 2, 2004; 279(1): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. E. Curry Jr. and K. G. Osteen
The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle
Endocr. Rev., August 1, 2003; 24(4): 428 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Khosravi and P. C. K. Leung
Differential Regulation of Gonadotropin-Releasing Hormone (GnRH)I and GnRHII Messenger Ribonucleic Acid by Gonadal Steroids in Human Granulosa Luteal Cells
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 663 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C.-S. Chou, H. Zhu, E. Shalev, C. D. MacCalman, and P. C. K. Leung
The Effects of Gonadotropin-Releasing Hormone (GnRH) I and GnRH II on the Urokinase-Type Plasminogen Activator/Plasminogen Activator Inhibitor System in Human Extravillous Cytotrophoblasts in Vitro
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5594 - 5603.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Q. Li, H. Wang, Y. Zhao, H. Lin, Q. A. Sang, and C. Zhu
Identification and specific expression of matrix metalloproteinase-26 in rhesus monkey endometrium during early pregnancy
Mol. Hum. Reprod., October 1, 2002; 8(10): 934 - 940.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Manase, T. Endo, H. Henmi, Y. Kitajima, K. Yamazaki, A. Nishikawa, T. Mitaka, H. Sato, and R. Kudo
The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea
Mol. Hum. Reprod., August 1, 2002; 8(8): 742 - 749.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Zhang, L. Yan, M. A. Moses, and P. C.W. Tsang
Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum
Biol Reprod, July 1, 2002; 67(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. A. Ricke, G. W. Smith, L. P. Reynolds, D. A. Redmer, and M. F. Smith
Matrix Metalloproteinase (2, 9, and 14) Expression, Localization, and Activity in Ovine Corpora Lutea Throughout the Estrous Cycle
Biol Reprod, April 1, 2002; 66(4): 1083 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Kim, M. Hong, J. Kim, H. Kim, S.-J. Lee, S. Goo Kang, and D. Jae Cho
Bovine Follicular Fluid and Serum Share a Unique Isoform of Matrix Metalloproteinase-2 That Is Degraded by the Oviductal Fluid
Biol Reprod, December 1, 2001; 65(6): 1726 - 1731.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.